Bessemer Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26K Buy
169
+31
+22% +$3.37K ﹤0.01% 1905
2026
Q1
$13K Buy
138
+88
+176% +$8.84K ﹤0.01% 2039
2025
Q4
$5K Hold
50
﹤0.01% 2252
2025
Q3
$3K Hold
50
﹤0.01% 2234
2025
Q2
$3K Hold
50
﹤0.01% 2128
2025
Q1
$2K Sell
50
-5
-9% -$216 ﹤0.01% 2228
2024
Q4
$2K Hold
55
﹤0.01% 2210
2024
Q3
$1K Buy
+55
New +$1.56K ﹤0.01% 2410
2023
Q2
Sell
-56
Closed -$1K 2290
2023
Q1
$1K Buy
+56
New +$1.6K ﹤0.01% 1856
2021
Q4
Sell
-158
Closed -$20K 1897
2021
Q3
$20K Buy
+158
New +$18.8K ﹤0.01% 1232

Other funds holding GH

Bessemer Group's GH Position: Q2 2026 in Review

Bessemer Group increased its Guardant Health (GH) stake by 22% in Q2 2026, buying an estimated $3.37K and bringing the position to 169 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Bessemer Group first reported a position in GH in Q3 2021 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bessemer Group held 169 shares of Guardant Health worth $26K as of Q2 2026.
  • Bessemer Group bought 31 Guardant Health shares in Q2 2026, an estimated $3.37K.
  • Guardant Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1905 holding.
  • Bessemer Group first reported a position in Guardant Health in Q3 2021 and has held it in 10 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.